Ganga Pharmaceuticals Salute del bilancio
Salute finanziaria criteri di controllo 5/6
Ganga Pharmaceuticals has a total shareholder equity of ₹70.5M and total debt of ₹13.6M, which brings its debt-to-equity ratio to 19.3%. Its total assets and total liabilities are ₹86.5M and ₹16.0M respectively. Ganga Pharmaceuticals's EBIT is ₹84.2K making its interest coverage ratio -0.1. It has cash and short-term investments of ₹298.3K.
Informazioni chiave
19.3%
Rapporto debito/patrimonio netto
₹13.58m
Debito
| Indice di copertura degli interessi | -0.1x |
| Contanti | ₹298.30k |
| Patrimonio netto | ₹70.53m |
| Totale passività | ₹15.95m |
| Totale attività | ₹86.48m |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: 539680's short term assets (₹57.5M) exceed its short term liabilities (₹12.0M).
Passività a lungo termine: 539680's short term assets (₹57.5M) exceed its long term liabilities (₹4.0M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 539680's net debt to equity ratio (18.8%) is considered satisfactory.
Riduzione del debito: 539680's debt to equity ratio has reduced from 36.3% to 19.3% over the past 5 years.
Copertura del debito: 539680's operating cash flow is negative, therefore debt is not well covered.
Copertura degli interessi: 539680 earns more interest than it pays, so coverage of interest payments is not a concern.